| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| April 22, 2026 | ±3.1% | +7.2% | under-priced |
| October 22, 2025 | ±2.4% | +13.9% | under-priced |
| July 23, 2025 | ±1.8% | -1.8% | under-priced |
| April 23, 2025 | ±3.0% | +1.9% | over-priced |
| October 18, 2024 | ±1.6% | +10.0% | under-priced |
| July 19, 2024 | ±2.5% | +9.3% | under-priced |
| April 19, 2024 | ±2.9% | -1.7% | over-priced |
| October 20, 2023 | ±2.9% | -2.4% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $2.28 | $2.8B | $826M |
| Q4 FY2025 | $2.20 | $2.9B | $800M |
| Q3 FY2025 | $1.95 | $2.5B | $709M |
| Q2 FY2025 | $1.81 | $2.4B | $664M |
Intuitive Surgical Inc. (ISRG) reports in 85 days, with the next report estimated for September 6, 2026. Across the last 8 reports, options priced an average ±2.5% earnings move while the stock actually moved 6.0% on average — the market has been roughly fair on ISRG's earnings risk. Fundamentals into the print: EPS up 18.7% year-over-year, revenue up 23.0%. QuantLogix's live 5-factor engine currently reads ISRG as a buy at 52/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →